ZoomInfo Technologies Inc. (NASDAQ:GTM) Receives $11.67 Average PT from Analysts

ZoomInfo Technologies (GTM) has received an average 'Reduce' rating from analysts, with a consensus price target of $11.67, despite some recent target price increases to neutral. This contrasts with the company's strong Q3 earnings, which significantly beat estimates with $0.28 EPS and $318 million in revenue, marking 4.7% year-over-year growth and positive FY25 guidance. However, recent insider selling by the CRO and General Counsel, totaling 11,142 shares valued at over $124,000, presents a mixed signal for investors.

Analysis

ZoomInfo Technologies (NASDAQ:GTM) presents a complex investment profile, marked by strong recent financial performance contrasting with a predominantly cautious analyst sentiment. The company reported robust Q3 earnings, significantly exceeding analyst expectations, yet maintains an average "Reduce" rating from ten covering firms, creating a nuanced outlook.

For Q3, GTM reported $0.28 EPS, surpassing the $0.17 consensus by $0.11, and revenue reached $318.00 million against estimates of $303.86 million. This represented a 4.7% year-over-year revenue increase, supported by a 14.55% return on equity and an 8.40% net margin. The company also provided optimistic FY 2025 EPS guidance of $1.040-$1.060.

Despite these strong financials, the average analyst price target stands at $11.67, with four "sell" and five "hold" recommendations contributing to the "Reduce" consensus. Adding to this caution, recent insider selling activity includes the CRO divesting 3,288 shares and the General Counsel selling 6,600 shares on November 4th, representing an 18.86% reduction in her ownership.

The stock's minimal 0.2% decline suggests the market is processing these conflicting signals, weighing strong operational performance and guidance against prevailing analyst skepticism and notable insider divestment, which may indicate concerns about future growth sustainability or valuation.

Key Decisions for Investors

• Investors should carefully weigh ZoomInfo's strong Q3 earnings beat and positive FY25 guidance against the prevailing "Reduce" average analyst rating and the relatively low average price target of $11.67.
• The significant insider selling, particularly the recent transactions by the CRO and General Counsel, warrants close scrutiny as it may signal executive concerns despite reported financial strength.
• Consider monitoring future revenue growth rates and any further insider transaction disclosures, as these will be critical indicators for GTM's long-term trajectory and valuation.